Literature DB >> 8905170

The amyloid precursor protein of Alzheimer's disease is found on the surface of static but not activity motile portions of neurites.

E Storey1, T Spurck, J Pickett-Heaps, K Beyreuther, C L Masters.   

Abstract

We have previously found that the amyloid precursor protein (APP) of Alzheimer's disease is present on the surface of rat cortical neurons in culture, in a segmental pattern which first becomes evident after 24 hours and is fully developed by five days. As APP has previously been reported to have a short half-life in neuronal cell lines, and has been shown to contain binding sites for various extracellular matrix components within its extracellular domain, we hypothesized that APP would be associated with portions of neurites undergoing rapid structural change, such as growth cones. To test this hypothesis, we observed selected neurons by video time-lapse differential interference microscopy on 24-hour-old primary rat neuronal cultures for up to 45 minutes, followed by fixation and immunocytochemistry to ascertain surface APP distribution on those same neurons. In contrast to our predictions, surface APP was not found on active portions of neurites, even if the activity produced no net translational movement. This result indicates that surface APP is actually associated with stable portions of neurites, a conclusion that tallies with other recent results showing that neuronal surface APP has a longer half-life than general cellular APP, and is associated with markers of adhesion patches, which themselves are relatively stable structures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905170     DOI: 10.1016/0006-8993(96)00609-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

2.  Disease-modifying treatments for Alzheimer's disease.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

3.  Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  Int J Clin Exp Med       Date:  2010-05-15

Review 4.  Physiological functions of APP family proteins.

Authors:  Ulrike C Müller; Hui Zheng
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

5.  Dopamine promotes cathepsin B-mediated amyloid precursor protein degradation by reactive oxygen species-sensitive mechanism in neuronal cell.

Authors:  Sanju Kumari; Abhishek Mukherjee; Chinmay K Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2018-10-22       Impact factor: 3.396

Review 6.  Amyloid precursor protein trafficking, processing, and function.

Authors:  Gopal Thinakaran; Edward H Koo
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

7.  Biology and pathophysiology of the amyloid precursor protein.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2011-04-28       Impact factor: 14.195

8.  The amyloid precursor protein: beyond amyloid.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2006-07-03       Impact factor: 14.195

9.  The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques.

Authors:  Patty C Kandalepas; Katherine R Sadleir; William A Eimer; Jie Zhao; Daniel A Nicholson; Robert Vassar
Journal:  Acta Neuropathol       Date:  2013-07-03       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.